Search Results

Response to Raschi E et al. 'Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction'.

• Authors : Gupta MA; Department of Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.; Vujcic B

Subjects: Hidradenitis Suppurativa*; Adalimumab ; Humans

• Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2020 Aug; Vol. 34 (8), pp. e431-e432. Date of Electronic Publication: 2020 AprPublisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. .; Polizzi S

• Source: Drug safety [Drug Saf] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports: A Note of Caution.

• Authors : Fusaroli M; Khouri C; Poluzzi E

Subjects: Meta-Analysis as Topic*; Humans ; Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/statistics & numerical data

• Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Jul-Aug 01; Vol. 44 (4), pp. 443-444. Date of Electronic Publication: 2024 Jun 21.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.

• Authors : Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. .; Salvo F

Subjects: Pharmacovigilance* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Peer Review*

• Source: Drug safety [Drug Saf] 2024 Jul; Vol. 47 (7), pp. 601-605. Date of Electronic Publication: 2024 Mar 18.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports.

• Authors : Crescioli G; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy.

Subjects: Serenoa*/Serenoa*/Serenoa*/adverse effects ; Prostatic Hyperplasia*/Prostatic Hyperplasia*/Prostatic Hyperplasia*/drug therapy; Male

• Source: Phytotherapy research : PTR [Phytother Res] 2023 Nov; Vol. 37 (11), pp. 5289-5299. Date of Electronic Publication: 2023 Jul 18.Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1573

Record details

Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

• Authors : Khouri C; Pharmacovigilance Unit, Grenoble Alpes University Hospital, Université Grenoble Alpes, F-38000 Grenoble, France.; HP2, Inserm U1300, Université Grenoble Alpes, Grenoble, France.

• Source: Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2024 Sep 12; Vol. 17, pp. 17562864241276847. Date of Electronic Publication: 2024 Sep 12 (Print Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2856 (Print)

Record details

TO SHOw how we have been ENgaged in the APS FiELD (What we learned on APS collaborating with Professor Yehuda Shoenfeld).

• Authors : Meroni PL; Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy. Electronic address: .; Borghi MO

Subjects: Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/immunology ; Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/Antibodies, Antiphospholipid*/metabolism ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/immunology

• Source: Autoimmunity reviews [Autoimmun Rev] 2024 Sep; Vol. 23 (9), pp. 103613. Date of Electronic Publication: 2024 Aug 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128967 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The evolving role of disproportionality analysis in pharmacovigilance.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Raschi E

Subjects: Pharmacovigilance* ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/epidemiology ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data

• Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Aug; Vol. 23 (8), pp. 981-994. Date of Electronic Publication: 2024 Jun 24.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database.

• Authors : de Filippis R; Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100, Catanzaro, Italy. .; Kane JM

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Pharmacovigilance* ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/epidemiology

• Source: Drug safety [Drug Saf] 2024 Aug; Vol. 47 (8), pp. 745-757. Date of Electronic Publication: 2024 May 09.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality.

• Authors : Schoretsanitis G; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York.; Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, Glen Oaks, New York.

Subjects: Liraglutide*/Liraglutide*/Liraglutide*/therapeutic use ; Liraglutide*/Liraglutide*/Liraglutide*/adverse effects ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/adverse effects

• Source: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2423385. Date of Electronic Publication: 2024 Aug 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System.

• Authors : Xia S; Department of Pharmacy, The Second Xiangya Hospital, Central South University, 139# Renmin Middle Road, Furong District, Changsha, 410011, China.; International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, 410011, China.

• Source: Clinical drug investigation [Clin Drug Investig] 2023 Oct; Vol. 43 (10), pp. 773-783. Date of Electronic Publication: 2023 Sep 27.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians.

• Authors : Raschi E; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. .; Rossi S

Subjects: Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced ; Myocarditis*/Myocarditis*/Myocarditis*/diagnosis

• Source: Drug safety [Drug Saf] 2023 Sep; Vol. 46 (9), pp. 819-833. Date of Electronic Publication: 2023 Jun 21.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. .; Salvo F

Subjects: Adverse Drug Reaction Reporting Systems* ; Drug-Related Side Effects and Adverse Reactions*; Humans

• Source: Drug safety [Drug Saf] 2023 Sep; Vol. 46 (9), pp. 857-866. Date of Electronic Publication: 2023 Jul 08.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug-drug interactions in clinical practice.

• Authors : Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.; Poluzzi E

Subjects: Adverse Drug Reaction Reporting Systems* ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/prevention & control; Humans

• Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Aug; Vol. 89 (8), pp. 2365-2368. Date of Electronic Publication: 2023 May 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals.

• Authors : Lunghi C; Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. .; Population Health and Optimal Health Practices Research Unit, CHU de Québec-Université Laval Research Centre, Quebec, Quebec, Canada. .

Subjects: Inappropriate Prescribing*/Inappropriate Prescribing*/Inappropriate Prescribing*/prevention & control ; Potentially Inappropriate Medication List* ; Polypharmacy*

• Source: Drug safety [Drug Saf] 2024 Nov; Vol. 47 (11), pp. 1061-1074. Date of Electronic Publication: 2024 Jul 11.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.

• Authors : Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. .; Salvo F

Subjects: Pharmacovigilance* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/standards

• Source: Drug safety [Drug Saf] 2024 Jun; Vol. 47 (6), pp. 585-599. Date of Electronic Publication: 2024 May 07.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.

• Authors : Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Salvo F

Subjects: Pharmacovigilance* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/standards ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data

• Source: Drug safety [Drug Saf] 2024 Jun; Vol. 47 (6), pp. 575-584. Date of Electronic Publication: 2024 May 07.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System.

• Authors : Cecco S; Hospital Pharmacy Unit-CRO Aviano, National Cancer Institute, IRCCS, 33081, Aviano, PN, Italy. .; Puligheddu S

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; United States Food and Drug Administration* ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/adverse effects

• Source: Targeted oncology [Target Oncol] 2024 May; Vol. 19 (3), pp. 435-445. Date of Electronic Publication: 2024 May 02.Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.

• Authors : Menniti-Ippolito F; National Center for Drug Research and Evaluation, National Institute of Health, Rome, Italy.; Aiello E

Subjects: Dietary Supplements*/Dietary Supplements*/Dietary Supplements*/adverse effects; Humans ; Europe/Europe/Europe/epidemiology

• Source: Drug safety [Drug Saf] 2023 May; Vol. 46 (5), pp. 435-437. Date of Electronic Publication: 2023 Apr 06.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.

• Authors : Gastaldon, C.; Arzenton, E.; Raschi, E.

Subjects: ANTIDEPRESSANTS; DATABASES; NEONATAL abstinence syndromeWORLD Health Organization

• Source: Psychological Medicine; Sep2023, Vol. 53 Issue 12, p5645-5653, 9p

Record details

Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Pellegrini L

Subjects: Disruptive, Impulse Control, and Conduct Disorders*/Disruptive, Impulse Control, and Conduct Disorders*/Disruptive, Impulse Control, and Conduct Disorders*/diagnosis; Humans ; Comorbidity

• Source: Addiction (Abingdon, England) [Addiction] 2023 Apr; Vol. 118 (4), pp. 763-770. Date of Electronic Publication: 2022 Dec 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences (DIMEC), Università di Bologna, Bologna, Italy.; Giunchi V

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Disruptive, Impulse Control, and Conduct Disorders*/Disruptive, Impulse Control, and Conduct Disorders*/Disruptive, Impulse Control, and Conduct Disorders*/chemically induced ; Disruptive, Impulse Control, and Conduct Disorders*/Disruptive, Impulse Control, and Conduct Disorders*/Disruptive, Impulse Control, and Conduct Disorders*/drug therapy

• Source: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2023 Mar; Vol. 77 (3), pp. 160-167. Date of Electronic Publication: 2022 Dec 21.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Symmetrical cutaneous rash in two women.

• Authors : Orioni G; Dermatology Unit IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna Bologna Italy.

• Source: Clinical case reports [Clin Case Rep] 2024 Apr 30; Vol. 12 (5), pp. e8877. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101620385 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0904

Record details

Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward.

• Authors : Poluzzi E; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Raschi E

• Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Mar 22. Date of Electronic Publication: 2024 Mar 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS.

• Authors : Fusaroli M; Unit of Pharmacology, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. .; Giunchi V

Subjects: Adverse Drug Reaction Reporting Systems* ; Drug-Related Side Effects and Adverse Reactions*; United States

• Source: Drug safety [Drug Saf] 2024 Mar; Vol. 47 (3), pp. 271-284. Date of Electronic Publication: 2024 Jan 04.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details